Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Odyssey Therapeutics, Inc. (ODTX : NSDQ)

• Company Description    - Number of Employees: 100

• Price / Volume Information    Yesterday's Closing Price: $18.66 Daily Weekly Monthly 20 Day Moving Average: 305,115 shares Shares Outstanding: 48.03 (millions) Market Capitalization: $896.26 (millions) Beta: 52 Week High: $20.30 52 Week Low: $15.10 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 4.83% 4.06% 12 Week % % Year To Date % %

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 51 Sleeper Street Suite 800 - Boston,MA 02210 USA ph: 617-865-9628 fax: - investors@odysseytx.com https://odysseytx.com

• General Corporate Information    Officers Gary D. Glick - Chief Executive Officer and President Jeffrey M. Leiden - Chairman Jason Haas - Chief Financial Officer Collin Todd - Senior Vice President Jill Carroll - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 67613T104 SIC: 2836 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 09/16/26 Share - Related Items Shares Outstanding: 48.03 Most Recent Split Date: (:1) Beta: Market Capitalization: $896.26 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.88 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-4.58 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 5.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 09/16/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 06/30/26 - - 03/31/26 - - 12/31/25 - - ROA 06/30/26 - - 03/31/26 - - 12/31/25 - - Current Ratio 06/30/26 - - 03/31/26 - 8.33 12/31/25 - - Quick Ratio 06/30/26 - - 03/31/26 - 8.33 12/31/25 - - Operating Margin 06/30/26 - - 03/31/26 - - 12/31/25 - - Net Margin 06/30/26 - - 03/31/26 - - 12/31/25 - - Pre-Tax Margin 06/30/26 - - 03/31/26 - - 12/31/25 - - Book Value 06/30/26 - - 03/31/26 - - 12/31/25 - - Inventory Turnover 06/30/26 - - 03/31/26 - - 12/31/25 - - Debt-to-Equity 06/30/26 - - 03/31/26 - - 12/31/25 - - Debt-to-Capital 06/30/26 - - 03/31/26 - 0.00 12/31/25 - -

Powered by Zacks Investment Research ©